Learn more at LeadIQ.com

Insights

Gathering insights about NEC OncoImmunity AS…

Similar companies to NEC OncoImmunity AS

NEC OncoImmunity AS Tech Stack

NEC OncoImmunity AS uses 8 technology products and services including Google Analytics, GitHub, Docker, and more. Explore NEC OncoImmunity AS's tech stack below.

Google Analytics
Analytics
GitHub
Communication And Collaboration
Docker
Containerization
Google Cloud Platform
Infrastructure As A Service
Google
Miscellaneous
PHP
Programming Languages
Python
Programming Languages
Animate.css
UI Frameworks

Media & News

NEC OncoImmunity AS's Email Address Formats

NEC OncoImmunity AS uses at least 1 format(s):

NEC OncoImmunity AS Email Formats	Example	Percentage
First@oncoimmunity.com	John@oncoimmunity.com	50%
First@oncoimmunity.com	John@oncoimmunity.com	50%

Frequently Asked Questions

Where is NEC OncoImmunity AS's headquarters located?

NEC OncoImmunity AS's main headquarters is located at Ullernchausséen 64 Oslo, Oslo 0379 NO. The company has employees across 2 continents, including EuropeAsia.

What is NEC OncoImmunity AS's official website and social media links?

NEC OncoImmunity AS's official website is oncoimmunity.com and has social profiles on LinkedIn.

How much revenue does NEC OncoImmunity AS generate?

As of October 2024, NEC OncoImmunity AS's annual revenue reached $3.8M.

What is NEC OncoImmunity AS's SIC code NAICS code?

NEC OncoImmunity AS's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does NEC OncoImmunity AS have currently?

As of October 2024, NEC OncoImmunity AS has approximately 34 employees across 2 continents, including EuropeAsia. Key team members include Chief Executive Officer: S. N.Chief Scientific Officer: K. B.Co-Founder And Advisor: R. S.. Explore NEC OncoImmunity AS's employee directory with LeadIQ.

What industry does NEC OncoImmunity AS belong to?

NEC OncoImmunity AS operates in the Biotechnology Research industry.

What technology does NEC OncoImmunity AS use?

NEC OncoImmunity AS's tech stack includes Google AnalyticsGitHubDockerGoogle Cloud PlatformGooglePHPPythonAnimate.css.

What is NEC OncoImmunity AS's email format?

NEC OncoImmunity AS's email format typically follows the pattern of . Find more NEC OncoImmunity AS email formats with LeadIQ.

How much funding has NEC OncoImmunity AS raised to date?

As of October 2024, NEC OncoImmunity AS has raised $4.8M in funding. The last funding round occurred on Apr 12, 2022 for $4.8M.

When was NEC OncoImmunity AS founded?

NEC OncoImmunity AS was founded in 2014.

NEC OncoImmunity AS

NEC OncoImmunity AS

Biotechnology ResearchOslo, Norway11-50 Employees

NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning software, which addresses the key gaps in the prediction of bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines.
We are dedicated to developing scalable software solutions that facilitate effective patient selection for cancer immunotherapy, and identifying optimal neoantigen targets for truly personalized cancer vaccines & cell therapies in a clinically actionable time frame.
Our growing international team (13 countries and counting!) consists of a diverse mix of data scientists, bioinformaticians, immunologists, cancer researchers, and software developers.
NEC OncoImmunity AS is a subsidiary of the NEC Corporation, and is based in the Oslo Cancer Cluster buildings in Oslo, Norway.

Company Overview

Headquarters: Ullernchausséen 64 Oslo, Oslo 0379 NO
Website: oncoimmunity.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2014
Employees: 11-50

Media & News

Funding & Financials

$4.8M
NEC OncoImmunity AS has raised a total of $4.8M of funding over 3 rounds. Their latest funding round was raised on Apr 12, 2022 in the amount of $4.8M.
$10M
NEC OncoImmunity AS's revenue is in the range of $10M

Funding & Financials

$4.8M
NEC OncoImmunity AS has raised a total of $4.8M of funding over 3 rounds. Their latest funding round was raised on Apr 12, 2022 in the amount of $4.8M.
$10M
NEC OncoImmunity AS's revenue is in the range of $10M

Company Leadership

S. N.
Chief Executive Officer
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. B.
Chief Scientific Officer
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. S.
Co-Founder And Advisor
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. C.
Cso (co-Founder)
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. N.
Quality Assurance & Regulatory Affairs Manager
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

B. S.
Data Science Manager
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. M.
Infectious Disease Bioinformatics Manager
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
H. F.
Senior Manager (personalized Cancer Vaccines)
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
I. V.
Data Science Manager
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. M.
Software Development Manager
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for NEC OncoImmunity AS and Millions of Other Companies
Sign up for full access to NEC OncoImmunity AS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.